posted on 2023-03-31, 16:05authored byAndrew C. Dudley, Michael Klagsbrun
Related Article from Tumor Endothelial Cells Join the Resistance
History
ARTICLE ABSTRACT
The field of antiangiogenesis research has been met with some surprises, including the realization that tumor blood vessels are more complex and labile than expected. In this issue of Clinical Cancer Research, Xiong and colleagues show that tumor-specific endothelial cells are less sensitive to cytotoxic and antiangiogenic drugs compared to their normal counterparts.
